Calavo gains with avocados, strawberries blossom statewide
By Marissa Wenzke / Friday, April 3rd, 2015 / Agribusiness, Columns, Latest news, Top Stories, Tri-County Public Companies / Comments Off on Calavo gains with avocados, strawberries blossom statewide
The Tri-Counties was hit with at least $10 million in lost crop revenue last year, but there are still a good number of bright spots in ag.
Read More →Amgen touts positive results with new heart health drug
By Erika Martin / Friday, March 20th, 2015 / Central Coast Health Watch, East Ventura County, Latest news, Technology, Top Stories, Tri-County Public Companies / Comments Off on Amgen touts positive results with new heart health drug
If approved, it will be the Thousand Oaks-based biotech giant’s first new drug on the market since the FDA’s landmark approval of the first-ever biosimilar drug on the American market.
Read More →Tri-county public company ranks shrink as Vitesse sells for $389M
By Staff Report / Wednesday, March 18th, 2015 / Latest news, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies, West Ventura County / Comments Off on Tri-county public company ranks shrink as Vitesse sells for $389M
The deal values Vitesse at $5.28 per share, a premium of 32 percent over the stock’s 30-day average closing price.
Read More →Calavo shares shoot up on Q1 earnings
By Staff Report / Friday, March 6th, 2015 / Agribusiness, Earnings, Latest news, South Coast, Top Stories, Tri-County Public Companies / Comments Off on Calavo shares shoot up on Q1 earnings
Santa Paula-based Calavo Growers roared out of the gate with a profit of $5.3 million in its fiscal 2015 first quarter, according to a release from the company. The company’s shares jumped nearly 6.5 percent to $45.05 at the market’s close. After recording a $1.8 million loss in the same period last year, Calavo appears Read More →
Read More →Amgen’s portfolio threatened as FDA paves path for lower-cost drugs
By Staff Report / Friday, March 6th, 2015 / Latest news, Technology, Top Stories, Tri-County Public Companies / Comments Off on Amgen’s portfolio threatened as FDA paves path for lower-cost drugs
Zarxio, the first biopharmaceutical copycat approved in the U.S., will pave the way for lower-cost alternatives to existing treatments.
Read More →Amgen profit tops analysts’ estimates on drug sales, tax credit
By Staff Report / Friday, January 30th, 2015 / Central Coast Health Watch, East Ventura County, Latest news, Subscriber content, Technology, Top Stories, Tri-County Public Companies / Comments Off on Amgen profit tops analysts’ estimates on drug sales, tax credit
Amgen, the nation’s biggest biotech company, reported fourth-quarter profits that beat analysts’ estimates, aided by a tax benefit and higher-than-estimated sales of arthritis drug Enbrel.
Read More →Region’s crop producers take stock
By Elijah Brumback / Friday, January 30th, 2015 / Agribusiness, Latest news, Top Stories, Tri-County Public Companies / Comments Off on Region’s crop producers take stock
The region’s main avocado and citrus growers are facing two very different situations — one bright, the other less so.
Read More →Popular articles
- None Found
Sponsored content:
SHIPS SLOW TO PROTECT WHALES, BLUE SKIES
-
Sign up for email news
Get the Business Times in your inbox. Sign up for breaking news alerts, our weekly briefing, and more.Sign upFor Email Marketing you can trust.2015-2016 Giving Guide
Check out our 2015 Giving Guide special issue